Sanchez-Fueyo A - Search Results

1

Selective decrease of donor-reactive T_regs after liver transplantation limits T_reg therapy for promoting allograft tolerance in humans.

Tang Q, Leung J, Peng Y, Sanchez-Fueyo A, Lozano JJ, Lam A, Lee K, Greenland JR, Hellerstein M, Fitch M, Li KW, Esensten JH, Putnam AL, Lares A, Nguyen V, Liu W, Bridges ND, Odim J, Demetris AJ, Levitsky J, Taner T, Feng S. Tang Q, et al. Among authors: sanchez fueyo a. Sci Transl Med. 2022 Nov 2;14(669):eabo2628. doi: 10.1126/scitranslmed.abo2628. Epub 2022 Nov 2. Sci Transl Med. 2022. PMID: 36322627 Free PMC article. Clinical Trial.

2

High amino acid variability within the NS5A of hepatitis C virus (HCV) is associated with hepatocellular carcinoma in patients with HCV-1b-related cirrhosis.

Giménez-Barcons M, Franco S, Suárez Y, Forns X, Ampurdanès S, Puig-Basagoiti F, Sánchez-Fueyo A, Barrera JM, Llovet JM, Bruix J, Sánchez-Tapias JM, Rodés J, Saiz JC. Giménez-Barcons M, et al. Hepatology. 2001 Jul;34(1):158-67. doi: 10.1053/jhep.2001.25512. Hepatology. 2001. PMID: 11431747

3

Physiological mechanisms of regulating alloimmunity: cytokines, CTLA-4, CD25+ cells, and the alloreactive T cell clone size.

Sho M, Yamada A, Najafian N, Salama AD, Harada H, Sandner SE, Sanchez-Fueyo A, Zheng XX, Strom TB, Sayegh MH. Sho M, et al. J Immunol. 2002 Oct 1;169(7):3744-51. doi: 10.4049/jimmunol.169.7.3744. J Immunol. 2002. PMID: 12244168

4

Persistent hypertransaminasemia as the presenting feature of celiac disease.

González-Abraldes J, Sánchez-Fueyo A, Bessa X, Moitinho E, Feu F, Mas A, Escorsell A, Bruguera M. González-Abraldes J, et al. Am J Gastroenterol. 1999 Apr;94(4):1095-7. doi: 10.1111/j.1572-0241.1999.01021.x. Am J Gastroenterol. 1999. PMID: 10201490

5

Interaction of Tim-3 and Tim-3 ligand regulates T helper type 1 responses and induction of peripheral tolerance.

Sabatos CA, Chakravarti S, Cha E, Schubart A, Sánchez-Fueyo A, Zheng XX, Coyle AJ, Strom TB, Freeman GJ, Kuchroo VK. Sabatos CA, et al. Nat Immunol. 2003 Nov;4(11):1102-10. doi: 10.1038/ni988. Epub 2003 Oct 12. Nat Immunol. 2003. PMID: 14556006

6

[Diagnosis of Wilson's disease].

Bustamante Schneider J, Bataller Alberola R, Sánchez Fueyo A. Bustamante Schneider J, et al. Gastroenterol Hepatol. 1997 Dec;20(10):510-3. Gastroenterol Hepatol. 1997. PMID: 9508488 Review. Spanish. No abstract available.

7

The treatment of ascites.

González-Abraldes J, Sánchez-Fueyo A, Arroyo V. González-Abraldes J, et al. Acta Gastroenterol Belg. 1999 Jan-Mar;62(1):41-6; discussion 46-8. Acta Gastroenterol Belg. 1999. PMID: 10333598 Review. No abstract available.

8

The complement dependent cytotoxicity (CDC) immune effector mechanism contributes to anti-CD154 induced immunosuppression.

Sánchez-Fueyo A, Domenig C, Strom TB, Zheng XX. Sánchez-Fueyo A, et al. Transplantation. 2002 Sep 27;74(6):898-900. doi: 10.1097/00007890-200209270-00031. Transplantation. 2002. PMID: 12364878 Free PMC article.

9

Infection with a novel human DNA virus (TTV) has no pathogenic significance in patients with liver diseases.

Giménez-Barcons M, Forns X, Ampurdanés S, Guilera M, Soler M, Soguero C, Sánchez-Fueyo A, Mas A, Bruix J, Sánchez-Tapias JM, Rodés J, Saiz JC. Giménez-Barcons M, et al. J Hepatol. 1999 Jun;30(6):1028-34. doi: 10.1016/s0168-8278(99)80256-6. J Hepatol. 1999. PMID: 10406180

10

Genetic evolution of GB virus C/hepatitis G virus (GBV-C/HGV) under interferon pressure.

Giménez-Barcons M, Sánchez-Fueyo A, Ampurdanés S, Puig-Basagoiti F, Guilera M, Ibáñez A, Clotet B, Martínez MA, Rodés J, Saiz JC, Sánchez-Tapias JM. Giménez-Barcons M, et al. Antiviral Res. 2000 May;46(2):157-70. doi: 10.1016/s0166-3542(00)00079-6. Antiviral Res. 2000. PMID: 10854667

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

127 results

Search Page